EUCOPE Blog

Showing all entries tagged with »medicines«


December 19, 2022

Launch Conditionality: What’s at stake?

Based on current discussions by the European Commission, launch conditionalities would not account for the distinct nature of small and mid-sized companies, OMPs and ATMPs. EUCOPE’s Alexander Natz breaks down this aspect of the revision of the General Pharmaceutical Legislation… read more



April 27, 2022

Five Priorities for a Successful EU HTA Procedure

With the European Union’s new Regulation (EU) 2021/2282 on health technology assessment, the evaluation of certain new therapies will now be performed jointly at the European level for the first time. The aims are to speed up access to new… read more


February 26, 2021

HERA: closer coordination in the EU against COVID-19

On 27 January, the European Commission launched the consultation on the European Health Emergency Preparedness and Response Authority, HERA for short. The consultation, which main aim is to issue a legislative proposal on the new authority by the end of… read more